top of page


NIAID Expert Panel Members to Discuss New Guidelines, and What they Mean for You Kids With Food Allergies (KFA), a division of The Asthma and Allergy Foundation of America (AAFA) will be hosting a webinar tomorrow to discuss the NIAID’s release of new clinical guidelines that will aid health care providers in early introduction of peanut-containing foods to infants.Our presenters, who were on the NIAID’s expert panel, will discuss how and why the new guidelines were created, the research behind them, risk levels, and ways to incorporate these guidelines into your daily life. WHO: Matthew Greenhawt, MD, MBA, MSc, is a pediatric allergist and co-director of the Food Challenge and Research Unit at Children's Hospital of Colorado and an assistant professor at the University of Colorado School of Medicine. Carina Venter, PhD, RD, is a research associate and dietitian at the Division of Allergy and Immunology, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio. WHAT: Three guidelines for introducing peanut-containing foods to infants to reduce the risk of developing peanut allergy: · Guideline 1: Infants at high risk of developing peanut allergy due to severe eczema, egg allergy, or both should have peanut-containing foods introduced into their diets as early as 4 to 6 months of age. · Guideline 2: Infants with mild or moderate eczema should have peanut-containing foods introduced into their diets around 6 months of age. · Guideline 3: Infants without eczema or any food allergy have peanut-containing foods freely introduced into their diets. WHERE: Register Here: WHEN: Thursday, January 26th at 3:00 PM EST WHY: Peanut allergy is a growing health problem for which no treatment or cure exists. Development of the Addendum Guidelines was prompted by emerging data suggesting that peanut allergy can be prevented by the early introduction of peanut-containing foods. Clinical trial results reported in February 2015 showed that regular peanut consumption begun in infancy and continued until 5 years of age led to an 81 percent reduction in development of peanut allergy in infants deemed at high risk. This finding came from the landmark, NIAID-funded Learning Early About Peanut Allergy (LEAP) study, a randomized clinical trial involving more than 600 infants. NIAID established a coordinating committee in 2015 which convened a 26-member expert panel of specialists from a variety of relevant clinical, scientific and public health areas. The draft guidelines were available on the NIAID website for public comment, and the expert panel and coordinating committee reviewed the 104 comments received to develop the final Addendum Guidelines.


bottom of page